Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… Mr. Wolin spent 10 years in the pharmaceutical industry in drug safety and regulatory affairs. He has worked in a … and cell therapy (autologous). Mr. Wolin has led numerous Food and Drug Administration meetings (pre-IND, end of phase 2, and …
… with preparing evidence dossiers for submission to the Food and Drug Administration and developing research proposals for … of Turkey, with a particular focus on peer-reviewed publications in the fields of medicine, veterinary medicine, …
… researchers conducted a systematic literature review (SLR) to identify studies that examined the … and young adults in the United States: a systematic review. Masaquel C, Schley K, Wright K, Mauskopf J, Parrish …
… Director, Health Economics Transcript As disease-modifying therapies for Alzheimer’s disease, or AD, enter the market, …
Psychometric Evaluation Our psychometricians have extensive experience conducting quantitative evaluations of COAs, evaluating their structure and demonstrating their reliability, validity, and responsiveness, as well as facilitating the interpretation of …
… loss with teriflunomide versus other disease-modifying therapies in relapsing multiple sclerosis: a systematic review and network meta-analysis. Ainsworth C, Higuchi K, …
… which applies to all new oncology drugs and cell and gene therapies beginning January 2025, orphan medicinal products …
… and /or modification of critical patient-reported outcome (PRO) questionnaires. In addition to project … protocols, technical reports, regulatory documents, and Food and Drug Administration (FDA) submissions; the coordination of …
… Gilsenan, PhD, MS, RPh, FISPE of RTI Health Solutions Gene therapies offer unprecedented opportunities to address rare …
Josephine Mauskopf Appointed Distinguished Fellow by RTI International Share on: September 22, 2022 Josephine (Jo) Mauskopf, PhD, MHA, Vice President of Health Economics at RTI Health Solutions, has been appointed as a Distinguished Fellow at RTI …